Logo image of XHR

XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis

NYSE:XHR - New York Stock Exchange, Inc. - US9840171030 - REIT - Currency: USD

12.175  +0.09 (+0.7%)

Fundamental Rating

4

Taking everything into account, XHR scores 4 out of 10 in our fundamental rating. XHR was compared to 129 industry peers in the Diversified REITs industry. XHR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XHR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

XHR had positive earnings in the past year.
XHR had a positive operating cash flow in the past year.
In multiple years XHR reported negative net income over the last 5 years.
Of the past 5 years XHR 4 years had a positive operating cash flow.
XHR Yearly Net Income VS EBIT VS OCF VS FCFXHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

XHR's Return On Assets of 0.79% is in line compared to the rest of the industry. XHR outperforms 53.49% of its industry peers.
XHR's Return On Equity of 1.88% is in line compared to the rest of the industry. XHR outperforms 51.94% of its industry peers.
The Return On Invested Capital of XHR (2.70%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for XHR is in line with the industry average of 3.15%.
Industry RankSector Rank
ROA 0.79%
ROE 1.88%
ROIC 2.7%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
XHR Yearly ROA, ROE, ROICXHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 2.15%, XHR is in line with its industry, outperforming 45.74% of the companies in the same industry.
XHR's Profit Margin has declined in the last couple of years.
XHR's Operating Margin of 8.84% is on the low side compared to the rest of the industry. XHR is outperformed by 79.84% of its industry peers.
In the last couple of years the Operating Margin of XHR has declined.
The Gross Margin of XHR (54.48%) is worse than 74.42% of its industry peers.
XHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.84%
PM (TTM) 2.15%
GM 54.48%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
XHR Yearly Profit, Operating, Gross MarginsXHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, XHR has less shares outstanding
The number of shares outstanding for XHR has been reduced compared to 5 years ago.
The debt/assets ratio for XHR has been reduced compared to a year ago.
XHR Yearly Shares OutstandingXHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
XHR Yearly Total Debt VS Total AssetsXHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

XHR has an Altman-Z score of 0.57. This is a bad value and indicates that XHR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.57, XHR is in line with its industry, outperforming 52.71% of the companies in the same industry.
XHR has a debt to FCF ratio of 49.38. This is a negative value and a sign of low solvency as XHR would need 49.38 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 49.38, XHR is doing good in the industry, outperforming 64.34% of the companies in the same industry.
XHR has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
XHR has a Debt to Equity ratio of 1.17. This is comparable to the rest of the industry: XHR outperforms 53.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 49.38
Altman-Z 0.57
ROIC/WACC0.36
WACC7.46%
XHR Yearly LT Debt VS Equity VS FCFXHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

XHR has a Current Ratio of 1.02. This is a normal value and indicates that XHR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of XHR (1.02) is comparable to the rest of the industry.
XHR has a Quick Ratio of 1.02. This is a normal value and indicates that XHR is financially healthy and should not expect problems in meeting its short term obligations.
XHR's Quick ratio of 1.02 is in line compared to the rest of the industry. XHR outperforms 55.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
XHR Yearly Current Assets VS Current LiabilitesXHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.79% over the past year.
XHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.70% yearly.
Looking at the last year, XHR shows a small growth in Revenue. The Revenue has grown by 3.57% in the last year.
Measured over the past years, XHR shows a decrease in Revenue. The Revenue has been decreasing by -1.99% on average per year.
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%87.5%
Revenue 1Y (TTM)3.57%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%8.01%

3.2 Future

XHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.53% yearly.
Based on estimates for the next years, XHR will show a small growth in Revenue. The Revenue will grow by 3.17% on average per year.
EPS Next Y243.4%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue Next Year1.52%
Revenue Next 2Y2.45%
Revenue Next 3Y3.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XHR Yearly Revenue VS EstimatesXHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
XHR Yearly EPS VS EstimatesXHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 55.34, XHR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of XHR is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.17. XHR is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 43.36, the valuation of XHR can be described as expensive.
Based on the Price/Forward Earnings ratio, XHR is valued a bit cheaper than the industry average as 62.79% of the companies are valued more expensively.
XHR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 55.34
Fwd PE 43.36
XHR Price Earnings VS Forward Price EarningsXHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XHR is valued a bit cheaper than 74.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, XHR is valued a bit cheaper than 62.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 41.67
EV/EBITDA 11.2
XHR Per share dataXHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XHR's earnings are expected to grow with 42.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y36.82%
EPS Next 3Y42.53%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.48%, XHR is a good candidate for dividend investing.
XHR's Dividend Yield is slightly below the industry average, which is at 6.93.
Compared to an average S&P500 Dividend Yield of 2.40, XHR pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.48%

5.2 History

The dividend of XHR decreases each year by -15.89%.
XHR has paid a dividend for at least 10 years, which is a reliable track record.
XHR has decreased its dividend recently.
Dividend Growth(5Y)-15.89%
Div Incr Years1
Div Non Decr Years1
XHR Yearly Dividends per shareXHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

XHR pays out 166.74% of its income as dividend. This is not a sustainable payout ratio.
DP166.74%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
XHR Yearly Income VS Free CF VS DividendXHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
XHR Dividend Payout.XHR Dividend Payout, showing the Payout Ratio.XHR Dividend Payout.PayoutRetained Earnings

XENIA HOTELS & RESORTS INC

NYSE:XHR (5/29/2025, 2:32:03 PM)

12.175

+0.09 (+0.7%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners96.16%
Inst Owner Change-0.14%
Ins Owners0.91%
Ins Owner Change0.04%
Market Cap1.20B
Analysts74.55
Price Target12.92 (6.12%)
Short Float %2.64%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield 4.48%
Yearly Dividend0.47
Dividend Growth(5Y)-15.89%
DP166.74%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-30 2025-06-30 (0.14)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.68%
Min EPS beat(2)-199.01%
Max EPS beat(2)163.65%
EPS beat(4)3
Avg EPS beat(4)3.8%
Min EPS beat(4)-199.01%
Max EPS beat(4)163.65%
EPS beat(8)5
Avg EPS beat(8)60.16%
EPS beat(12)7
Avg EPS beat(12)107.12%
EPS beat(16)9
Avg EPS beat(16)83.21%
Revenue beat(2)1
Avg Revenue beat(2)1.13%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)3.88%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)3.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.46%
Revenue beat(12)5
Avg Revenue beat(12)0.59%
Revenue beat(16)9
Avg Revenue beat(16)1.91%
PT rev (1m)-18.28%
PT rev (3m)-28.03%
EPS NQ rev (1m)300%
EPS NQ rev (3m)179.35%
EPS NY rev (1m)391.95%
EPS NY rev (3m)70%
Revenue NQ rev (1m)-4.08%
Revenue NQ rev (3m)-5.62%
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-3.09%
Valuation
Industry RankSector Rank
PE 55.34
Fwd PE 43.36
P/S 1.13
P/FCF 41.67
P/OCF 6.2
P/B 0.99
P/tB 1
EV/EBITDA 11.2
EPS(TTM)0.22
EY1.81%
EPS(NY)0.28
Fwd EY2.31%
FCF(TTM)0.29
FCFY2.4%
OCF(TTM)1.96
OCFY16.12%
SpS10.74
BVpS12.25
TBVpS12.2
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 1.88%
ROCE 3.41%
ROIC 2.7%
ROICexc 2.81%
ROICexgc 2.86%
OM 8.84%
PM (TTM) 2.15%
GM 54.48%
FCFM 2.72%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.99%
ROICexgc(5y)N/A
ROCE(3y)3.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.41%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 49.38
Debt/EBITDA 6.35
Cap/Depr 126.88%
Cap/Sales 15.55%
Interest Coverage 1.29
Cash Conversion 86.6%
Profit Quality 126.64%
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 0.57
F-Score6
WACC7.46%
ROIC/WACC0.36
Cap/Depr(3y)167.19%
Cap/Depr(5y)114.68%
Cap/Sales(3y)21.77%
Cap/Sales(5y)17.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%87.5%
EPS Next Y243.4%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue 1Y (TTM)3.57%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%8.01%
Revenue Next Year1.52%
Revenue Next 2Y2.45%
Revenue Next 3Y3.17%
Revenue Next 5YN/A
EBIT growth 1Y3.25%
EBIT growth 3YN/A
EBIT growth 5Y-8.94%
EBIT Next Year188.72%
EBIT Next 3Y48.07%
EBIT Next 5YN/A
FCF growth 1Y-73.85%
FCF growth 3Y37.05%
FCF growth 5YN/A
OCF growth 1Y4.85%
OCF growth 3Y58.91%
OCF growth 5Y-7.87%